D-hBD3 Alleviates Periodontitis and Systemic Inflammation via a Gut–Oral Axis through Dectin-1-Associated Modulation of Microbial Tryptophan Metabolism
Inflammation · 20.11.2026
DOI: 10.1007/s10753-026-02654-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, online erschienen am 20.11.2026. Verfasst von Miaomiao Zhang und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deakin University.
Abstract (Originalsprache)
Periodontitis causes alveolar bone loss, systemic inflammation, and gut dysbiosis, which are poorly resolved by conventional local therapies. Oral gavage of D-enantiomeric human β-defensin 3 (D-hBD3) sustains intestinal homeostasis and ameliorates periodontitis, yet the detailed mechanisms remain unclear. This study provides supporting evidence for a plausible gut–oral axis mechanism underlying D-hBD3-mediated periodontitis protection. A ligature-induced mouse periodontitis model was utilized to assess therapeutic outcomes of D-hBD3 oral gavage, D-hBD3 combined with a Dectin-1 antagonist, and fecal microbiota transplantation. Evaluations covered alveolar bone loss, serum lipopolysaccharide and interleukin-6 levels, and intestinal barrier integrity. Intestinal macrophage polarization, tight junction protein expression, and gut microbiota composition were analyzed, while multi-omics and correlation analyses characterized host and microbial tryptophan metabolic alterations and core regulatory molecules. D-hBD3 treatment and microbiota transplantation reduced alveolar bone resorption, restored intestinal barrier integrity, and alleviated systemic inflammation. Pharmacological Dectin-1 inhibition partially abolished these protective effects, supporting the involvement of Dectin-1 signaling in this protective phenotype. D-hBD3 activates intestinal macrophage Dectin-1 signaling, promotes M2 polarization, and upregulates tight junction proteins, thereby remodeling gut microbiota by enriching Bifidobacterium and depleting Akkermansia and Escherichia . D-hBD3 remodels tryptophan metabolism, elevating indole-3-carboxaldehyde and suppressing serotonin pathway metabolites. These microbial ligands positively correlate with Dectin-1 and extracellular matrix remodeling genes and negatively correlate with pro-inflammatory Stat1 . D-hBD3 ameliorates periodontitis via the gut–oral axis through a Dectin-1-associated gut microbiota–tryptophan metabolism cascade, revealing the promising potential of gut-targeted defensins as adjunctive periodontitis therapeutics.
Förderung
- Deakin University
Zitieren
APA
Zhang, M., Ni, C., Li, L., Cui, D., Chen, R., Wei, Y., Yang, W., Yan, F., & Li, Y. (2026). D-hBD3 Alleviates Periodontitis and Systemic Inflammation via a Gut–Oral Axis through Dectin-1-Associated Modulation of Microbial Tryptophan Metabolism. Inflammation. https://doi.org/10.1007/s10753-026-02654-9
Vancouver
Zhang M, Ni C, Li L, Cui D, Chen R, Wei Y, et al. D-hBD3 Alleviates Periodontitis and Systemic Inflammation via a Gut–Oral Axis through Dectin-1-Associated Modulation of Microbial Tryptophan Metabolism. Inflammation. 2026. doi:10.1007/s10753-026-02654-9
BibTeX
@article{Zhang2026,
author = {Zhang, Miaomiao and Ni, Can and Li, Lingjun and Cui, Di and Chen, Rixin and Wei, Yuan and Yang, Wenrong and Yan, Fuhua and Li, Yanfen},
title = {D-hBD3 Alleviates Periodontitis and Systemic Inflammation via a Gut–Oral Axis through Dectin-1-Associated Modulation of Microbial Tryptophan Metabolism},
journal = {Inflammation},
year = {2026},
doi = {10.1007/s10753-026-02654-9}
}
EUVIMED